Table 1.
Bioassay targets are confirmed as AML active proteins by literature searches and associated binding proteins are predicted by Ontomine.
| S. no | Ontomine predicted bioassays |
Confidence level | Compound(s) | Reference no |
|---|---|---|---|---|
| 1 | Guanine nucleotide binding protein, alpha activating polypeptide-O |
Medium | Honokiol | [13] |
| Low | Cholecalciferol Limonene Retinyl palmitate |
|||
|
| ||||
| 2 | Multidrug resistance protein 1 | Low | Mevinolin Limonene Resveratrol Chrysin |
[14] |
|
| ||||
| 3 | Myeloid or lymphoid or mixed-lineage leukaemia protein | High | Aloe emodin Mevinolin |
[15] |
| Low | Barbaloin Limonene Retinyl palmitate Cholecalciferol Chrysin L-Ascorbic acid 6-palmitate |
|||
|
| ||||
| 4 | Runt-related transcription factor 1 isoform AML1c | High | Chrysin | [16] |
| Medium | Honokiol | |||
| Low | Barbaloin Mevinolin Limonene L-Ascorbic acid 6-palmitate |
|||